Board of Aurobindo Pharma recommends interim dividend
(04 Aug 2025)

Back
Aurobindo Pharma announced that the Board of Directors of the Company at its meeting held on 4 August 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 400%) , subject to the approval of the shareholders.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew